# Corticosteroid Injection Combined With Cataract Surgery in Diabetic Eyes.

> **NCT05413330** · PHASE2,PHASE3 · COMPLETED · sponsor: **Damascus University** · enrollment: 73 (actual)

## Conditions studied

- Diabete Type 2
- Cataract
- Triamcinolone Acetonide
- Intravitreal Injection

## Interventions

- **DRUG:** Triamcinolone Acetonide

## Key facts

- **NCT ID:** NCT05413330
- **Lead sponsor:** Damascus University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-12
- **Primary completion:** 2022-01-05
- **Final completion:** 2022-03-29
- **Target enrollment:** 73 (ACTUAL)
- **Last updated:** 2023-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05413330

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05413330, "Corticosteroid Injection Combined With Cataract Surgery in Diabetic Eyes.". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05413330. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*